CMPX vs IP · $367.4M cap vs P/E 43, $26.62B cap
Compass Therapeutics Inc. (CMPX) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
International Paper (IP) is a packaging & containers company listed on US.
CMPX does not have a complete income-statement cache yet.
IP does not have a complete income-statement cache yet.
CMPX currently screens at market cap $367.4M. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the CMPX and IP stock pages for the full models.
Not investment advice.